The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

21 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
19
Identification of Novel GPR55 Modulators Using Cell-Impedance-Based Label-Free Technology.EBI
Instituto De Qu£Mica M£Dica
7
Design, synthesis, and analysis of antagonists of GPR55: Piperidine-substituted 1,3,4-oxadiazol-2-ones.EBI
University of North Carolina At Greensboro
4
Indoloditerpenes from a marine-derived fungal strain of Dichotomomyces cejpii with antagonistic activity at GPR18 and cannabinoid receptors.EBI
University of Bonn
45
8-Benzamidochromen-4-one-2-carboxylic acids: potent and selective agonists for the orphan G protein-coupled receptor GPR35.EBI
University of Bonn
67
Antagonists for the orphan G-protein-coupled receptor GPR55 based on a coumarin scaffold.EBI
University of Bonn
8
Magnolia Extract, Magnolol, and Metabolites: Activation of Cannabinoid CB2 Receptors and Blockade of the Related GPR55.EBI
University of Bonn
42
Emerging targets in osteoporosis disease modification.EBI
Amgen
29
Stereoisomers of cannabidiols and their pharmacological activities - A potentially novel direction for cannabinoids.EBI
University Health Network
25
Thienopyrimidine Derivatives as GPR55 Receptor Antagonists: Insight into Structure-Activity Relationship.EBI
IQM-CSIC
7
Phytocannabinoid Pharmacology: Medicinal Properties of EBI
Scientus Pharma
19
Discovery of Tricyclic Xanthines as Agonists of the Cannabinoid-Activated Orphan G-Protein-Coupled Receptor GPR18.EBI
University of Bonn
5
The Essential Medicinal Chemistry of Cannabidiol (CBD).EBI
University of Minnesota
9
Discovery of 1,4-Naphthoquinones as a New Class of Antiproliferative Agents Targeting GPR55.EBI
University of Calabria
17
Potent and selective N-(4-sulfamoylphenyl)thiourea-based GPR55 agonists.EBI
University of Eastern Finland
34
Structure-activity relationships of imidazothiazinones and analogs as antagonists of the cannabinoid-activated orphan G protein-coupled receptor GPR18.EBI
University of Bonn
24
Design, synthesis and biological evaluation of GPR55 agonists.EBI
University of North Carolina At Greensboro
18
Diaryl macrocycles as modulators of protein kinasesBDB
Tp Therapeutics
234
Biaryl kinase inhibitorsBDB
Bristol Myers Squibb
130
Compounds useful for treating disorders related to RETBDB
Blueprint Medicines
30
Stereospecific high-affinity TRPV1 antagonists: chiral N-(2-Benzyl-3-pivaloyloxypropyl) 2-[4-(methylsulfonylamino)phenyl]propionamide analogues.BDB
Seoul National University
9
Isoform selective inhibition of STAT1 or STAT3 homo-dimerization via peptidomimetic probes: structural recognition of STAT SH2 domains.BDB
Yale University